Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet-activating factor in the CNS

K M Maclennan1, P F Smith, C L Darlington

  • 1Department of Pharmacology, School of Medical Sciences, University of Otago Medical School, Dunedin, New Zealand.

Progress in Neurobiology
|December 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New software dedicated to virtual mazes for human cognitive investigations.

Journal of neuroscience methods·2019
Same author

The critical role of vestibular graviception during cognitive-motor development.

Behavioural brain research·2019
Same author

Hippocampal LTP modulation and glutamatergic receptors following vestibular loss.

Brain structure & function·2018
Same author

Flow cytometry for receptor analysis from ex-vivo brain tissue in adult rat.

Journal of neuroscience methods·2018
Same author

Cost-utility analysis of antiviral use under pandemic influenza using a novel approach - linking pharmacology, epidemiology and heath economics.

Epidemiology and infection·2018
Same author

Further studies of the effects of aging on arginine metabolites in the rat vestibular nucleus and cerebellum.

Neuroscience·2017
Same journal

Deletion of Fbxo25 causes excessive repetitive behavior, impaired recognition memory, reduced dendritic complexity, and aberrant protein expression in mice.

Progress in neurobiology·2026
Same journal

Neuropsychiatric Disease Mechanisms and Interventions. from 22q11.2 Deletion Syndrome Experimental Studies.

Progress in neurobiology·2026
Same journal

REM sleep as a dummy-model of the world: A theoretical framework.

Progress in neurobiology·2026
Same journal

CA3 transiently modulates spatial representation in CA1.

Progress in neurobiology·2026
Same journal

Love, death, and oxytocin: In memory of Larry Young.

Progress in neurobiology·2026
Same journal

Assessing peripheral oxytocin and cortisol levels and epigenetic variations of oxytocin receptor and glucocorticoid receptor genes in school-aged preterm-born children.

Progress in neurobiology·2026
See all related articles

Platelet-activating factor (PAF) modulates central nervous system (CNS) processes and contributes to neuronal injury. PAF receptor antagonists offer potential therapeutic strategies for neurotrauma.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pharmacology

Background:

  • Platelet-activating factor (PAF) is a phospholipid synthesized by various cells.
  • PAF is present in the central nervous system (CNS) and has diverse physiological and pathological roles.

Purpose of the Study:

  • To explore the role of PAF in CNS processes.
  • To investigate the involvement of PAF in neuronal injury.
  • To assess the therapeutic potential of PAF receptor antagonists in neurotrauma.

Main Methods:

  • Literature review on PAF synthesis and function in the CNS.
  • Analysis of studies investigating PAF's role in neuroinflammation and neuronal differentiation.
  • Examination of research on PAF receptor antagonists in models of CNS injury.

Related Experiment Videos

Main Results:

  • PAF modulates key CNS processes, including long-term potentiation and neuronal differentiation.
  • Elevated PAF levels are implicated in neuronal damage from ischemia, inflammation, HIV, and meningitis.
  • PAF receptor antagonists demonstrate beneficial effects in neurotrauma contexts.

Conclusions:

  • PAF is a significant modulator of CNS function and a contributor to neuronal injury.
  • Targeting PAF receptors with antagonists presents a promising therapeutic avenue for neurotrauma and related neurological disorders.